My wife (stage IV breast cancer) started this protocol about six weeks ago. 

Her oncologist was skeptical citing a lack of studies. I asked her who would fund such a study and she agreed that the protocol would wreak havoc on the economic model of cancer treatments.

We won’t know whether it’s working for her for another few months but it seems to be an asymmetric bet (low downside high upside) worth taking.